Simvastatin

Generic Name
Simvastatin
Brand Names
Cholib, FloLipid, Simcor, Vytorin, Zocor
Drug Type
Small Molecule
Chemical Formula
C25H38O5
CAS Number
79902-63-9
Unique Ingredient Identifier
AGG2FN16EV
Background

Simvastatin, also known as the brand name product Zocor, is a lipid-lowering drug derived synthetically from a fermentation product of Aspergillus terreus. It belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage abnormal lipid levels by inhibiting the endogenous production of cholesterol in the liv...

Indication

Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL‑C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).
...

Associated Conditions
Cardiovascular Events, Diabetes Mellitus, Heterozygous Familial Hypercholesterolemia (HeFH), High Cholesterol, Homozygous Familial Hypercholesterolaemia (HoFH), Mixed Hyperlipidemia, History of coronary heart disease cardiovascular event, History of stroke or other cerebrovascular disease cardiovascular event
Associated Therapies
-
Clinical Trials
Related News

Niacin Plus Statin to Prevent Vascular Events

First Posted Date
2005-07-15
Last Posted Date
2016-04-06
Lead Sponsor
Axio Research. LLC
Target Recruit Count
3414
Registration Number
NCT00120289
Locations
🇺🇸

Clinical Research Consultants, Inc., Hoover, Alabama, United States

🇺🇸

VA Long Beach Healthcare System, Long Beach, California, United States

🇺🇸

Iowa Heart Center, P.C., Des Moines, Iowa, United States

and more 88 locations

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

Not Applicable
Completed
Conditions
Atherosclerosis
Interventions
Drug: simvastatin
First Posted Date
2005-06-16
Last Posted Date
2015-06-01
Lead Sponsor
Kurume University
Target Recruit Count
43
Registration Number
NCT00114504
Locations
🇯🇵

Kurume University Hospital, Kurume, Japan

Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)

Phase 2
Completed
Conditions
Transient Ischemic Attack
Stroke
First Posted Date
2005-04-27
Last Posted Date
2008-04-08
Lead Sponsor
University of Calgary
Target Recruit Count
500
Registration Number
NCT00109382
Locations
🇨🇦

Foothills Medical Centre, Calgary, Alberta, Canada

🇨🇦

Universtiy of Alberta Walter MacKenzie Health Sciences Centre, Edmonton, Alberta, Canada

🇨🇦

London Health Sciences Centre - University Hospital, London, Ontario, Canada

and more 15 locations

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

First Posted Date
2004-03-12
Last Posted Date
2006-11-01
Lead Sponsor
Kos Pharmaceuticals
Target Recruit Count
300
Registration Number
NCT00079638

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Phase 3
Completed
Conditions
Alzheimer Disease
First Posted Date
2003-02-04
Last Posted Date
2009-07-28
Lead Sponsor
National Institute on Aging (NIA)
Target Recruit Count
400
Registration Number
NCT00053599
Locations
🇺🇸

Neurological Care of NY, Syracuse, New York, United States

🇺🇸

University of Pennsylvania School of Medicine, Alzheimer's Disease Center, Philadelphia, Pennsylvania, United States

🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

and more 41 locations

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

First Posted Date
2001-08-31
Last Posted Date
2006-03-14
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
56
Registration Number
NCT00017758
Locations
🇺🇸

Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States

🇺🇸

Univ of Minnesota, Minneapolis, Minnesota, United States

🇺🇸

Washington Univ School of Medicine, St Louis, Missouri, United States

and more 7 locations

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
56
Registration Number
NCT00000941
Locations
🇺🇸

Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States

🇺🇸

San Francisco Gen Hosp, San Francisco, California, United States

🇺🇸

Stanford Univ Med Ctr, Stanford, California, United States

and more 10 locations

HDL-Atherosclerosis Treatment Study (HATS)

First Posted Date
1999-10-28
Last Posted Date
2016-02-10
Lead Sponsor
University of Washington
Registration Number
NCT00000553

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

First Posted Date
1999-10-19
Last Posted Date
2018-03-07
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
160
Registration Number
NCT00004266
Locations
🇺🇸

Hennepin County Medical Center, Minneapolis, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy